These medications were originally developed for diabetes management and are now widely recognized for their weight-loss benefits, Salkin explained
The frequent thoughts about food and cravings that can make managing weight difficult become less intrusive. In the OASIS 4 trial, participants achieved a mean weight loss of 16.6% over 64 weeks alongside structured lifestyle support. To find out more, download the guide Foundayo (Orforglipron) an investigational oral GLP-1 medication developed by Eli Lilly
However, recent clinical trials have demonstrated that the positive effect of these PPIs is primarily restricted to the upper gastrointestinal tract
This will provide a meaningful measure of efficacy in an early phase and is designed to strongly derisk the project
The mechanisms are not yet fully understood in humans, but preclinical studies point to several overlapping pathways, said Hsiangkuo (Scott) Yuan, MD, associate professor at Thomas Jefferson University, clinical research director at Jefferson Headache Center, and one of the study authors
Neither outcome represents a problem
